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Emerging health record platforms are interesting 
examples of the ongoing process of digitalization and 
the great opportunities they provide for innovation 
and additional services. Incumbent players are under 
increasing pressure from new entrants to offer their 
customers a user experience they have become 
familiar with through platforms such as Apple and 
Google. The emergence of the digital German health 
record is shown as a case-study, harnessing a 
longitudinal database and adopting a process-
sensitive perspective. Important events are structured 
into individual episodes and phases and discussed in-
depth. The study shows how platform owners of health 
records respond to changes in the highly regulated 
healthcare system and its digitalization in Germany. 
Contrasting with extant knowledge about 
interoperability as a relevant precondition for 
platforms, our study shows the important role played 
by interoperability as a design parameter for 
emerging platforms, which results in seven 
interoperability challenges for respective 
stakeholders. 
1.  Introduction  
Compared to other industries, the progress of 
digitalization is much slower in the healthcare sector 
[16]. Reasons include the necessary regulation within 
divergent national contextual frameworks, the 
presumption of market failure, the complex systems of 
care and treatment processes, the variety of 
stakeholders and heterogeneous systems and the lack 
of interoperability (e.g., [19]). One of the key 
applications, and the basis for various add-on services 
in healthcare, is the Electronic Health Record (EHR), 
which drives and underpins the digitalization of 
healthcare. Due to the slow progress of digitalization, 
the healthcare market still offers great potential for the 
development of innovative services [16]. The 
                                                 
1 Author´s translation from German into English  
chairman of the board of the Techniker Krankenkasse 
(TK), one of the leading statutory health insurance 
companies in Germany, communicated this very 
clearly in his vision for the TK at a key speech in 
October 2019:  
"TKs vision for 2030 is shaped by the conviction 
that people live in a few, relatively stable digital 
ecosystems with high levels of connectivity. Besides 
Apple and Amazon, a healthcare ecosystem is to be 
designed by TK with a quality and user experience on 
a par with Apple & Co. In this context, the regulatory 
authorities in Germany will hopefully prevent 
statutory health insurance companies from losing 
direct contact with the customer during the transition 
phase as well. The TK ecosystem will include data-
based services beyond the mandatory requirements 
(e.g., electronic patient files) and will persuade and 
inspire the loyalty of TK-insured persons in the long 
term. We will clearly use digitization to differentiate 
ourselves from the competition in order to achieve 
greater control of the provision of care"1 (Thomas 
Ballast 2019; Board member TK, Berlin #eHealthCon 
October 23, 2019). 
 In addition to this particular vision for the 
healthcare sector by this insurance company, the quote 
also elucidates the threat of new market entrants that it 
will have to deal with and how it will address these 
threats in terms of quality, user experience and service 
offerings. Health record platforms play a central role 
in this context. In order to develop the full potential of 
EHR, semantic interoperability, in addition to 
technical specifications, must be achieved despite its 
being one of the most challenging tasks in health 
informatics (e.g., [21]). Especially in the case of 
providers of national EHRs, such as for Denmark or 
Norway, a clear consensus about standards is 
necessary to ensure the proper exchange of 
information between different healthcare service 
providers and sectors in order to realize the benefits of 
platform-based coordination [14, 19, 1]. Germany's 





self-administered health system (consisting of 
associations, institutes and organizations of 
stakeholders in the health sector e.g., [23]) has not 
been able to reach a consensus of interoperability 
issues for decades. In 2019 and 2020, comprehensive 
changes have taken effect in order to regulate the 
digitalization of the German healthcare system records 
and promote innovative health services. This refers in 
particular to EHRs: by January 1, 2021, all statutory 
health insurance companies are required by law to 
provide their policyholders with an EHR. As of June 
2020, six potential providers—two insurance 
companies, Allgemeine Ortskrankenkasse (AOK) and 
TK, and four service providers (VIVY, IBM, 
Compugroup Medical and RISE)—have begun 
developing an EHR in response to governmental 
specifications. In the German context, health records 
can be differentiated into one of two types, as shown 
in Table 1. On the one hand, the EHR represents the 
governmental required minimal standard of a 
repository to store and exchange health status 
information, which is securely stored and shared with 
other institutions, based on the specifications of the 
regulatory authorities. The EHR facilitates the 
longitudinal sharing of medically relevant data, e.g., 
diagnosis, treatment activities, laboratory data and 
radiology reports, which can be exchanged among 
different health service providers across organizations 
[4, 19] and is primarily administered by physicians. 
On the other hand are provider-specific Personal 
Health Records (PHR) which include personal health 
information and which are primarily administered by 
the user [4, 19]. PHRs are an additional optional 
service of the EHR and provide the basis for data 
generation as well as complementary offers of mostly 
data-driven services within emerging provider-
specific health ecosystems. In this context, and as 
shown by Ballast’s quote above, it is in the interest of 
providers such as TK and AOK to establish multi-
sided health platforms, especially around the PHR, in 
order to offer a competitive additional benefit to 
interested insurants, by e.g. exclusive complementors 
and their digital services. Both records will be 
managed by the provider/platform owner, but in 
contrast to the PHR, the EHR will have to follow 
government specifications and regulations. Regarding 
PHRs, each of the platform owners address different 
interests and follow different design approaches over 
the course of implementation as well as different 
government structures and rules, e.g., relating to 
openness [31] of their boundary resources (e.g., [13]). 
Despite the fact that the EHR will only become 
mandatory in 2021, competition between platforms 
has already begun. In terms of interoperability, these 
government requirements impose various challenges 
for platform providers and platform owners. This leads 
to the following two research questions:  
RQ 1: How do PHR and their respective ecosystem 
develop differently over time in a highly 
regulated market?  
RQ 2: Which specific interoperability challenges can 
be observed prior to the official 
implementation of EHRs in Germany? 
In order to answer these questions, this study 
follows a research design in digital transformation and 
platformization (e.g., [11, 26]) in form of a 
longitudinal, processsensitive, comparative, 
embedded case study [9, 33]. The case will be 
analyzed on the basis of primary data (e.g., fieldnotes 
and interviews) and secondary data (e.g., press 
releases, professional articles, legal reforms) which 
will be compiled together in a digital case study 
database following Yin’s approach [33]. In research 
projects with long-term data, it is particularly 
important to observe the research phenomenon as a 
changing process over the development of the research 
project; however, there are very few precedents of this 
type of research (e.g., [11]). In the context of multi-
sided platforms (MSP), Fürstenau et al. [11] developed 
a design and management framework, which will be 
used to analyze and compare the differences between 
three selected PHR platforms in Germany during the 
emergence process. The framework was developed by 
Fürstenau et al. [11] as an extension of the integrative 
framework for platforms by Gawer & Cusumano [12]. 
It specifies the four strategic design dimensions 
(issues) manifested over the course of platform 
development and contextualizes the design of 
interoperability as an embedded and interdependent 
design parameter. 
2.  Conceptual Background 
2.1.  Multi-Sided Platforms in Germany 
Besides the described differences between PHRs 
and EHRs, another differentiation exists between 
government-regulated or open solutions [6], on a 
regional, national or institutional level. Additionally, 
the storage location of health records can be either 
Table 1: Types of health records in Germany 






















depending on the 
platform owner  
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centralized or decentralized (see Table 1). In 
Germany, the EHR will be a national, decentralized, 
government-regulated solution, which means that the 
data will be stored in the “primary information 
system” of the service provider who generates the 
EHR data. Other authorized service providers 
throughout the nation can retrieve requested health 
data. The data will be shared via the German health 
information exchange infrastructure, which is a 
nationwide secure Virtual Private Network (VPN), 
called Telematic Infrastructure (TI). The technical 
background processes as well as the user interface are 
supplied by the EHR provider (see Table 1) via the TI. 
Gematik as the lead organization is responsible for the 
technical specifications, standards, testing and 
operations of the TI. In contrast to the EHR, the PHR 
is specified by the providers or platform owners. 
Given that many different independent stakeholder 
groups – medical service providers, complementors of 
digital services, and patients – are involved, PHR 
Platforms can be understood as an MSP [5, 19, 32]. 
The success of MSPs is significantly influenced by 
network effects and a highly dynamic ecosystem [8, 
26]. Kapoor [18] understands an ecosystem as “a set 
of actors that contribute to the focal offer’s user value 
proposition” [18 p. 2]. Its actors would include, e.g., 
participating physicians, complementors of digital 
health services, insurants, and the insurance company. 
Concerning platforms and their respective ecosystems, 
Hein et al. [15] identified three central building blocks 
of a digital platform ecosystem, consisting of platform 
owner, value-creation mechanism and complementor. 
The value-creation mechanism facilitates the joint 
creation of value by the platform owner and 
complementors and provides a basis for promoting 
innovation within the platform ecosystem [15]. The 
platform owner basically determines the design, 
resources and management of the platform ecosystem 
[15] according to Fürstenau et al.’s [11] design and 
management framework. Choosing a mode of 
governance [26] is the responsibility of the platform 
owner, who also promotes innovation for the platform 
ecosystem, especially by third-parties who are 
respectively known as complementors [5].  
2.2.   Interoperability 
Our understanding of interoperability is related to 
the approach of the IEEE [17]. For MSPs, such as PHR 
platforms, interoperability is an essential precondition 
for exchanging data [10, 4, 3]. One requirement of 
Fürstenau et al.’s [11] framework, and also a key 
competitive parameter, is that the platform must be 
able to achieve direct network effects through 
standards and interfaces [8] as well as competitive 
advantages through the design of the integration and 
binding of complementors and customers. This 
requires a certain degree of openness/closeness (e.g., 
[31]) within the platform’s ecosystem, which can be 
achieved through the definition of governance rules 
for the boundary resources (e.g., [13]) and the 
selection of interface standards [27, 11]. In general, 
interoperability can be achieved through the use of 
standards, especially open standards. These standards 
can be assigned to different levels of interoperability 
according to their respective types. A distinction is 
made between technical, syntactical, semantical and 
pragmatic levels (e.g., [3, 25]). In order to implement 
a PHR/EHR system, the technical level will be 
represented by the IT architecture as well as its 
compliance to the TI. Syntactical and semantical 
interoperability refers to the format, especially 
regarding the ease of understanding the transmitted 
message. In order to benefit from the potential of 
health records (e.g., big data and machine learning 
algorithms), semantically interoperable data are 
required [21], i.e., the exchanged information must be 
able to be uniformly interpreted and understood (e.g., 
[3, 25]). 
3.   Method 
3.1.  Research design  
In order to answer the research questions, an 
essential understanding about the process and events 
is required, especially regarding the regulatory 
changes that will occur over the course of the 
emergence of the EHR and PHR platforms in 
Germany. These are part of an ongoing parallel and 
sequential chain of events. We understand events to be 
actions, reactions or decisions made by the platform 
owners, conceivable complementors (stakeholders) or 
government. Episodes are sequences of changes, e.g., 
by government, and resulting actions, reactions or 
decisions made by platform owners or complementors, 
as well as actions that occur during the process of the 
platform’s emergence. The dissemination of health 
platforms is dynamic, context-sensitive, and time-
specific and requires a longitudinal analysis study 
[32]. For a more nuanced understanding, the events 
can be considered on different levels as well as in the 
context of different issues in terms of platformization. 
Therefore, we have chosen a longitudinal, process-
sensitive and comparative perspective with an in-
depth view of platformization according to the 
platform management framework by Fürstenau et al. 
[11]. The overall study is designed as embedded case 
study following Eisenhardt [9] and Yin [33] and 
focusses on contemporary events.  
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3.2.  Case selection and data collection 
Germany has one of the oldest healthcare systems 
in the world. It follows a solidarity principle where 
every citizen is insured by one of the statutory health 
insurance providers (numbering 105, as of January 1, 
2020), with the exception of certain professional 
groups (e.g., soldiers, public servants, freelancers, or 
high earners). Measured in terms of GDP, Germany 
has the third highest health expenditure [24]. A deeper 
overview of the German healthcare system is provided 
by Obermann et al. [23] and Busse et al. [7]. Our study 
will focus on three emerging PHR platforms with the 
highest number of potential users and some interesting 
strategic differences. Two of the platform owners 
belong to the largest statutory health insurance 
companies in Germany, the AOK and the TK. In 
contrast to these incumbent companies, the third 
platform in our study is the entrant VIVY, a private 
company that offers a white label solution for statutory 
health insurance as well as for private insurance 
companies (see also [2]). Due to the high potential 
number of users and the significant differences in their 
PHR solutions, especially in terms of architecture, 
these three providers are compared in a comparative 
case study approach [33]. While designing our case 
study, we reconstructed the process of episodes as well 
as the relevant events involving the respective actors, 
including regulatory changes over time, and thus the 
emergence of the PHR platforms in Germany. We 
used different sources of data to avoid potential biases 
within the primary data, and triangulate the results 
obtained from different sources of secondary data. 
Table 2 presents an overview of the data used in the 
case study database [33].  
3.3.  Data preparation and analysis 
 The collected data is coded and structured by level 
of analysis, time stamp and influence directions 
according to the management framework developed 
by Fürstenau et al. [11]. Additionally, the temporal 
bracketing approach by Langley [20] is used to 
identify relevant events and episodes in the data. This 
structure enables a differentiation of the data and the 
selection of decisive events during the emergence of 
the EHR as well as the PHR platforms. In a further 
conceptualization, we distinguish between the 
upcoming events of different, partly interdependent 
levels of analysis in terms of the impact on the macro, 
meso or micro level (e.g., [22]). Events with a wide 
impact on the overall healthcare system can be 
assigned to the macro level, e.g., regulatory changes 
made by government. In contrast, the micro level will 
include events with a limited scope and impact, such 
as in a single organization or a small focus group. The 
meso level represents events in between the two, i.e., 
events orchestrated by the platform owner for their 
ecosystem or for their insurants. Events on this level 
have a wider impact on all their insurants and/or the 
respective ecosystem of the complementors of the 
emerging PHR platforms.  
In terms of the emergence of the case, we identified 
three overall phases for an initial structuring of the 
information on the macro level in the data. During the 
first Phase, I Experimental PHR phase, the insurance 
companies in particular were able to gain initial 
experience with a PHR. In the second phase, 
II Transition phase from PHR to EHR, it became 
obvious that an EHR will become mandatory 
according to specifications. In the third phase, III EHR 
becomes mandatory, the EHR will be introduced in 
Germany (on January 1, 2021). After this date, every 
statutory health insurance company must offer an EHR 
to its insurants. To structure and reconstruct the events 
and episodes of the platform’s emergence, we follow 
the four “issues” of Fürstenau et al.’s [11] platform 
design and management framework. The issues follow 
a platform management point of view on the micro and 
meso level relating to the platform owner. The first 
issue, 1) Developing strategy and governance model, 
refers to decisions about the vision and governance 
structures of the platform. Decisions about the 
architecture and interoperability of the platform can be 
coded as being part of the second issue, 2) Designing 
technical architecture and selecting standards. The 
third issue, 3) Facilitating participation and 
community building, refers to actions and decisions 
related to developing the community around the 
platform ecosystem. Decisions to form alliances with 
Table 2: Case study database 
Document type Document description Documents Pages 
Participatory 
observations 
Field notes from various events, including lectures and discussions by 
responsible stakeholder (from November 2018–May 2020) 
31 112 
Interviews Semi-structured and formally recorded and transcribed interviews with health 
startups (collected in 2019 as a pre-study) 
7 72 
Press releases Press releases, position papers, presentation slides, blog articles  59 246 
Professional articles Articles from professional digital health journals 28 212 
Legal reforms Legal reforms to digitize the German healthcare (2004–2020) 





Specifications Specification documents by regulatory authorities 6 422 
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platforms or authorities can be assigned to the last 
issue, 4) Engaging with the platform’s ecosystem and 
wider environment. By structuring the data as 
described, patterns and causal relationships can be 
systematically established to reconstruct the case and 
understand the impact of partially interlinked events 
i.e. actions, reactions and decisions. 
3.4.  Case analysis of the emergence of health 
record platforms in Germany 
3.4.1. Introduction to the case analysis. This section 
shows the dynamics within the emergence of the three 
focused PHRs/EHRs in Germany over a period of 
sixteen years. Starting from the regulatory changes on 
the macro level, the three PHR platforms on the micro 
and meso levels will be briefly explained. For this 
purpose, the events are categorized into the three 
distinct phases as well as the four issues identified by 
Fürstenau et al. [11]. Figure 1 gives an overview, with 
more details provided in the following subsections. 
3.4.2. The case from the macro level point of view. 
Initially, the emergence of health records can be 
described from a macro perspective, i.e., essential 
events, particularly governmental regulations and 
legislation as well as the establishment of 
infrastructure and the definition and selection of 
standards, which relates especially to issues 1) and 2).  
Phase I: Experimental phase of the PHR. The 
first identified phase starts in 2004 (01 Jan. 2004) 
when statutory health insurance companies were 
legally allowed to finance PHRs to improve quality 
and efficiency and to gain initial concrete experience 
in day-to-day healthcare practice provided by 
physicians. For twelve years (from 2004 to 2016), this 
self-administration was not in any way centrally 
managed or steered to provide a clear vision for the 
PHRs to interface with that of other service providers 
and to value-adding services to increase the 
attractiveness of the Telematic Infrastructure (TI). In 
December of 2018, gematik published the first version 
of an EHR, which will require an integrated 
application of the TI (19 Dec.2018). Contrary to expert 
opinions and European solutions with established 
standards, e.g., Integrated Healthcare Enterprises 
(IHE), gematik decided to follow a proprietary non-
internationally-standardized approach, which is not 
interoperable with other existing solutions on a 
technical or a syntactical level outside of the TI, i.e. 
with that of other nations. The development of TI was 
plagued by various problems, delays, inadequate 
regulations, outdated technologies, etc. (e.g., [30]). 
These were partly caused by disagreements among the 
shareholders and stakeholders. Overall, this episode is 
characterized by the failure of the system of self-
administration. The system could not gain sufficient 
momentum without hierarchical regulatory guidelines, 
due to direct and indirect network effects, and thus 
failed to support widespread EHR/PHR solutions. 
Vastly different particular interests (e.g., [28]) prevent 
agreement about necessary standards and 
specifications. After fourteen years, the government 
lost patience and intervened to demand greater 
consistency. In order to accelerate the process of 
digitalization of the healthcare system, the Federal 
Ministry of Health (FMH) took over the majority of 
gematik through the Appointment Service and Care 
Law (ASCL) (11 May 2019).  
During this first phase, initial solutions from 
German providers as well as internationally dominated 
PHR platforms (e.g., Google, Apple, etc.), which are 
also considered influential and relevant by PHR 
platform ecosystems, became established, despite the 
risk of as yet unknown standards and regulations. 
Phase: II Transition phase from PHR to EHR. 
With the ASCL (11 May 2019), wide-ranging 
regulations for EHR were established, including a date 
for the introduction of technical and infrastructural 
regulations. Additionally, the responsibilities of 
interoperability were clearly regulated and assigned 
according to layers of interoperability. Gematik is in 
charge of the technical and syntactical specifications 
of the EHR, especially the infrastructure, and the 
National Association of Statutory Health Insurance 
Physicians (ASHIPs) is responsible for establishing 
the syntactical and semantical specifications for the 
EHR content. For this purpose, so-called Medical 
Information Objects (MIO) are defined in order to 
determine the structure for health documents (i.e., 
doctor's letter or vaccination certificate etc.) in the 
EHR. Within this specification, the authorities define 
the regulatory framework according to issue 2), of 
Fürstenau et al. [11], regarding the design of the 
architecture and standards of the EHR. Based on this, 
the statutory health insurance companies can develop 
their own EHR/PHR solution, which puts them in 
direct competition with each other. With the resolution 
of the Digital Health Service Law (DHSL), Germany 
is the first country to enable the medical prescription 
of approved Digital Health Services (DHS) i.e., health 
apps (07 Nov. 2019) that will be financed by statutory 
health insurance companies, as is clearly regulated by 
the digital Health Applications Law (DHAL) (15 Jan. 
2020). This allows potential complements (DHS) for 
the PHRs/EHRs to be supported. The DHSs are also 
subject to interoperability requirements in order to 
transfer data to the EHR, which has been enforced by 
the Patient Data Protection Law (PDPL) (11 Apr. 
2020). This law represents a major breakthrough in 
Page 6187
terms of the semantical interoperability to build an 
interoperable digital healthcare system based on 
international standards with the acquisition of the 
license of the international semantic standard 
SNOMED CT. However, this only refers to the 
semantic part of coding and the uniform understanding 
of health information, but does not render the EHR 
interoperable internationally.  
Phase: III EHR becomes mandatory. According 
to the ASCL, when the EHR will be introduced (01 
Jan. 2021), each statutory health insurance company 
must offer its insurants an EHR that will take effect on 
January 1, 2021. One year later, the official financial 
support for PHRs will end. There will only be a single 
EHR for each insured person, as provided by his/her 
health insurance company. Additionally, it must be 
possible for insurants to transfer their data to another 
health insurance provider in the EHR, if necessary (01 
Jan. 2022). 
3.4.3. The case of TK and AOK from the meso and 
micro level point of view. In order to answer the 
research question, how PHR and their respective 
ecosystem develop differently over time in a highly-
regulated market, we focus in this and the subsequent 
section on the micro and meso level, i.e., the relevant 
events during the emergence of the PHR platforms. 
Initially, the parallels and differences of the incumbent 
players AOK and TK are described in more detail, 
whereas the entrant’s player VIVY will be described 
in the next section (3.4.4. ).  
Phase I: Experimental phase of the PHR. More 
than twelve years after the PHR was financially 
supported, the AOK is establishing a PHR solution (01 
June 2016). For this purpose, the AOK, as the largest 
association of health insurance companies with a total 
of 26 million insurants, is choosing a decentralized 
approach, i.e., the data will be stored by the healthcare 
provider who creates the health data for its patient. In 
terms of data access and exchange, the AOK is 
following international standards, particularly IHE 
integration profiles on technical and syntactical levels. 
The AOK seeks to establish a health network for the 
service providers, which relates to issue 3) by 
Fürstenau et al. [11] (13 Sept. 2016 and 10 Oct. 2017).  
The second largest health insurance company in 
Germany with around ten million insurants is also 
developing a PHR (21 Feb. 2017). In contrast to the 
AOK, the TK are following a centralized approach to 
data storage and developing the PHR together with 
their cooperating company, IBM (IBM Watson, see 
also [2]), which has many years of experience in data-
hosting and artificial intelligence (AI) in healthcare. 
With regard to the above-cited vision of the TK, its 
cooperation with IBM illustrates the added value that 
the TK can offer. This enables TK to operate a 
preventative care management by offering e.g. AI-
based value-added services to its insurants. Despite the 
different strategies and architectures (centralized/ 
decentralized) relating to issues 1) and 2 by Fürstenau 
et al. [11], the two largest insurance companies, AOK 
and TK decide to cooperate as co-opetition [27] (11-
Dec-2018) to enable data exchange among hospitals, 
insurance companies and PHRs via an interface based 
on the international IHE standard (11-Apr-2019).  
Phase: II Transition phase from PHR to EHR. 
Following the publication of the specifications by 
gematik and ASHIP, both insurance companies (AOK 
& TK) will be developing an EHR. Given the 
differences between the existing PHR solutions and 
the specified EHR in terms of architecture – according 
to a decentralized approach and interoperability 
following non-internationally standardized 
approaches – both platform owners decided to 
continue to offer their PHRs as an encapsulated 
solution. With their PHR platform, platform owners 
can offer complementary services to differentiate their 
business from the competition, while retaining the 
flexibility and control according to their own risk 
aversion (development risks).  
Relating to issue 4) Engaging with the platform’s 
ecosystem and wider environment [11], the AOK 
organized a community event with health startups to 
expand its PHR ecosystem, and to attract innovative 
services to their platform, as part of their offering to 
their insurants (07 Nov. 2019).  
Phase: III EHR becomes mandatory. As of 
January 1, 2021, all statutory health insurance 
companies are required by law to offer an EHR. One 
year later, insurants have to be able to transfer their 
EHR data to another statutory health insurance 
company, to allow insurants to switch. However, this 
only refers to interoperability of the specified EHR 
and not the PHR itself. Thus, some personal data and 
PHR specific services may not be transferable unless 
explicitly stipulated by law. 
3.4.4. The case of VIVY from the meso and micro 
level point of view. VIVY and its main shareholder 
Allianz (70%), offers a PHR solution for other health 
insurance companies. With the Allianz-Group, VIVY 
has an economically powerful partner which is one of 
the world’s leading insurance groups. However, 
Allianz in Germany focuses on private insurance and 
asset management products. In contrast to AOK’s and 
TK’s solutions, VIVY follows a centralized mobile 
approach with a greater focus on user experience and 
the autonomy of the data that comes through storing 
the data encrypted on the insurants’ mobile devices 
(see also [2]). 
Page 6188
Phase I: Experimental phase of the PHR. The IT 
service provider of the statutory health insurance 
companies (Bitmarck) assigned VIVY the contract to 
provide a PHR for their customers (statutory health 
insurance companies); therefore, VIVY became a 
supplier of PHRs for private and statutory insurance 
companies (01 May 2018). On September 17, 2018, 
VIVY released its PHR. Consequently, VIVY became 
the first platform owner of a PHR to provide a 
nationwide solution for all insurants of the contractual 
health insurance companies. This triggered network 
effects and VIVY quickly acquired additional health 
insurance companies (22 July 2019). At the time of 
writing (Oct. 2020), VIVY’s ecosystem includes 
twenty-nine statutory health insurance companies and 
four private health insurance companies, each with 
their own instance of PHR. A potential 19,4 million 
insurants can use their PHR. Additionally, VIVY is 
cooperating with several hospitals on the expansion of 
their ecosystems (12-Aug-2019).  
Phase: II Transition phase from PHR to EHR. 
After the announced specification and date of the 
EHR, VIVY will not offer an official EHR for 
statutory health insurance companies. Its strategy for 
this decision remains unclear, but may be based on the 
large architectural differences between its product and 
the general EHR specifications and regulatory 
requirements, or based on the fact that the customer 
group of the statutory insured do not fit the strategic 
focus of its shareholders. Therefore, the contract has 
been awarded to the provider RISE. Nevertheless, 
VIVY will still be seen by the contract partner as a 
provider of innovative solutions to connect 
complementors e.g., digital health applications such as 
Digital Health Service (DHS), and to offer innovative 
health services via their mobile PHR solution.  
4.  Discussion 
In order to answer the research questions, the key 
events in the emergence of the EHRs and PHR 
platforms were structured into phases and levels to 
show—on the basis of longitudinal data—how the 
ecosystems of the PHR platforms emerge. As a result, 
interoperability challenges at single points of time 
could be derived from the perspective of the respective 
stakeholders. 
Platform owners’ point of view: An initial 
challenge is the appropriate 1) timing of designing 
technical architecture and selecting standards, 
reflecting issue 2) by Fürstenau et al. [11]. During 
Phase I, the three platform owners have demonstrated 
a possible PHR design, showing how an EHR could 
potentially be structured in order to enter the 
Figure 1. Emergence and dynamics of three PHR platforms in Germany 
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discussion about technical and syntactical interface 
specifications on the macro level with gematik and the 
Association of Statutory Health Insurance Physicians, 
among others, during the transition to Phase II. This 
gives providers the opportunity to start diffusion 
processes at an early stage to promote network effects 
around their respective solutions and emerging 
ecosystems. At the same time, there is an investment 
and 2) the development risk of interfaces, especially in 
times of uncertainty regarding the final specifications. 
The uncertainty that characterized the transition from 
phase I to phase II is likely to have resulted in costs 
due to adjustments that had to be made to the 
interfaces, especially on a technical and a syntactical 
level. The platform owners AOK and TK have shown 
how an interface can work according to international 
standards, as it was to be expected that gematik would 
follow these standards. However, the published 
specification of the EHR does not follow IHE, the 
established international standard. Due to the high 
level of adaptation of the existing system, AOK and 
TK decided to develop separate solutions according to 
the national EHR specification. Therefore, the PHR 
from AOK and TK will be offered as an additional 
MSP-offering that fulfill the regulative basic 
affordances of an EHR but maintain the control and 
flexibility of the platform while promoting innovation 
and avoiding further development risks for their 
ecosystem. In contrast to the EHR, the platform 
owners of the PHR are free to make decisions about 
the design of the interfaces. This relates to issues 1) 
and 3) by Fürstenau et al. [11], and the degree of 
openness [31] via interfaces [27]. Platform owners 
have to 3) choose the appropriate Governance Mode 
[26] on the meso and micro levels of the platform’s 
ecosystem for co-opetition with competitors, and 
cooperation  with complementors [27] regarding 
interoperability requirements to promote innovations, 
e.g., by complementors such as Digital Health Service 
(DHS). The case of the co-opetition with the two 
incumbents AOK and TK shows that two competitors 
with partly different customer groups and a different 
platform architecture can cooperate in order to avoid 
being displaced by new entrants and to build solid and 
partly interoperable PHR platforms.  
Complementors’ point of view: This case also 
highlights the challenges for complementors. This 
includes 4) interoperability as a financing criterion of 
digital health services e.g., health startups, to be 
approved as (DHS) in the context of Germany. 
Therefore, interoperability has to be an integral part of 
the strategy to get financial support from statutory 
health insurance companies. Furthermore, 
interoperability via standard interfaces is a basic 
requirement of complementors connecting to 
PHR/EHR platform ecosystems [3, 4, 10, 11]. In 
Germany, this concerns at least five health startups 
during Phase II that have officially approved as DHS 
(fifteen have applied and will be reviewed, status as of 
November 2020) in order to be prescribed by 
physicians and reimbursed by the insurance 
companies. The different architectures of the 
platforms and governance modes of the platform 
owners result in another challenge for the 
complementors, namely to also 5) choose the 
appropriate platform in terms of interoperability. In 
addition to criteria relating to the size of the ecosystem 
and to potential users of the platforms, interoperability 
considerations are crucial, e.g., with regard to the type 
and nature of the data/information needed from the 
EHR and/or PHR. The adaptation effort to the PHR 
platform would be relevant in this context for the 
complementors. From a technical/syntactical point of 
view, the complementors has to determine whether the 
service requires the data/information from the EHR, 
e.g., doctor's reports, examination results, or from the 
PHR, such as self-collected vital parameters by the 
insurants. AI-based services, for instance, as probably 
intended e.g. by TK with its partner IBM Watson 
require more stringent interoperability requirements 
and semantic standards than less extensive services 
[21]. Based on well-coded health data/information, 
e.g., SNOMED CT, AI-based services can deliver 
better results [21]. Another factor arises among the 
different architectures of the platform (centralized/ 
decentralized) and respective access via e.g., 
standardized or less standardized interfaces – the 
amount of effort necessary for the integration depends 
on this. The respective adjustments and the threat of 
switching costs (for additional platforms, etc.) results 
in 6) binding effects for the complementors. Platform 
owners try to avoid multihoming, for users as well as 
complementors [29]. Detailed solutions within and 
between the emerging platform ecosystems, especially 
on a technical level, will be too different, e.g., in the 
case of VIVY. The health data would be stored directly 
on the device and could be accessed e.g., by App-
based services provided by the complementors, 
whereas in the case of AOK, the data would be stored 
in various decentralized IT infrastructures and would 
have to be retrieved first. This included necessary 
specifications for the concrete design and linking of 
business and supply processes, the coding of treatment 
and billing details, the supplementation of the 
regulatory EHR mandatory elements, and additional 
possibly ecosystem-specific value-added services.  
Insurants’ point of view: The case also shows 
some challenges for platform users, including the 
patients/insurants. When an insurant decides to switch 
their health insurance company, she/he can transfer 
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her/his EHR-specified data to the platform of the new 
statutory insurance company (from January 1, 2022). 
However, this does not apply to the additional data 
held in the PHR. Depending on the insurants’ personal 
data and additional, in some cases PHR-
exclusive/specific services, switching costs will result. 
This can lead to 7) lock-in effects to the initial platform 
and thus to the respective statutory health insurance 
company, effectively preventing multihoming by the 
platform owners [34]. This aspect would also be 
interesting regarding whether and what kind of role the 
emerging tech platforms and ecosystems of Apple, 
Google or Amazon, etc., will play and whether and 
how their health services can be tackled, integrated or 
combined with the respective PHR strategies by the 
incumbents, as mentioned by Thomas Ballast in his 
statement (p. 1). Apple, for example, is using the FHIR 
standard to integrate further health services, and it 
remains to be seen whether this will also apply to other 
record solutions.  
5.  Limitations and outlook 
The analysis and discussion of the case-study has 
certain limitations and carries implications for further 
research. In this study, the management and design 
framework by Fürstenau et al. [11] was applied from 
an external point of view, i.e., in some cases detailed 
background information would be necessary to 
elaborate on further instances. For the structuring of 
the events, three supplementary event types 
(governmental regulations, platform launch and non-
specific event) were used (see Figure 1). Some of the 
identified aspects are closely linked to this specific 
German case and are therefore not generally valid, 
which would have to be examined individually in 
future studies. 
As a brief outlook for this case, three aspects merit 
being further examined in future research. First, in 
response to the initial TK quote, it will be interesting 
to see if and how the relationship between the 
incumbent ecosystems and international tech giants 
like Google, Apple and Amazon will develop, 
considering that they have stated their intention to 
target health as their next big frontier. A “battle of the 
platforms” can be expected, which will be shaped by 
network effects and the decisions of complementors 
and insurants as well as regulators in response to the 
chosen strategies of the respective platform owners. 
Second, platform owners have to compete with each 
other for domination of the PHR/EHR market segment 
from 2021 onwards. The effects their chosen strategies 
will have on the attraction of complementors would 
represent another avenue for future study, particularly 
concerning platform architectures. Third, it would 
help to understand the internal view of 
complementors, including what challenges they 
perceive and how they deal with them. The existing 
demand for technical and economic strategies and 
principles during the emergence of EHR and PHR 
platforms in order to handle these challenges should 
be addressed in further research, e.g., following a 
design-oriented approach.  
6.  Conclusion 
The study makes the following contributions: First, 
in contrast to what we know about interoperability and 
platforms as pre-conditions [3, 4, 10] and design 
parameters [11, 19], especially in terms of openness 
[27], this study reveals the central role played by 
interoperability as a design parameter for emerging 
MSPs, and contributes to the interoperability 
discussions of MSPs, especially in healthcare. As part 
of this we identified seven key challenges for 
stakeholders, which are: For platform owners: 1) the 
timing of designing technical architecture and 
selecting standards, especially in periods of high 
uncertainty, especially 2) to avoid the development 
risk of interfaces and resulting adjustments; 3) 
platform owners have to choose the appropriate 
governance mode to balance interface openness, e.g., 
with competitors and complementors. 4) 
Interoperability can be a criterion for funding or 
reimbursement and should form part of their strategy, 
especially for complementors. 5) Complementors also 
have to choose the appropriate platform to generate 
interoperability i.e., interfaces and data composition. 
6) Proprietary adaptations to an ecosystem can also 
lead to binding effects. 7) From the perspective of the 
insurants, there are also challenges resulting from the 
lack of interoperability between PHR and other 
platforms, which may result in lock-in effects for the 
insurants to various, perhaps converging platforms of 
incumbents and entrants in health as one of the next 
big “digital transformation battle fields”. Second, a 
discussion and comparison between PHR platforms 
and the EHR points out the strategic differences 
between the three providers, which also leads to 
divergent architectural and interoperability challenges 
for complementors, insurants, and not least for 
platform owners themselves. Third, the study provides 
an overview of the significant changes in the German 
healthcare system triggered by digitalization and the 
emergence of MSP platforms and the EHR. Fourth, the 
discussion about the challenges has implications that 
can inform researchers as well as insurance companies 
or technical health service provider e.g. of health 
platforms, in Germany and also in other countries.  
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